Kaia Roman
Gründer bei KetaMD, Inc.
Profil
Kaia Roman is the founder of KetaMD, Inc. which was founded in 2019, where she holds the title of Chief Experience Officer.
She is currently a Venture Partner at Seedfund Capital since 2023.
Ms. Roman's former job was as Vice President, Strategy & Communications at Psycheceutical, Inc. from 2021 to 2023.
Ms. Roman received an undergraduate degree from New College of Florida.
Aktive Positionen von Kaia Roman
| Unternehmen | Position | Beginn |
|---|---|---|
KetaMD, Inc.
 KetaMD, Inc. Medical/Nursing ServicesHealth Services Part of Braxia Scientific Corp., KetaMD, Inc. operates as a telemedicine company. The company is based in Miami, FL. The company was founded in 2019 by Zappy Zapolin, Warren Gumpel, Leann Taylor, Kaia Roman. Warren Gumpel has been the CEO since 2019. KetaMD was acquired by Braxia Scientific Corp. on August 03, 2022 for $5.93 million. | Gründer | 01.01.2019 |
Seedfund Capital
 Seedfund Capital Investment ManagersFinance SeedFund Capital (SeedFund Capital) is a venture capital and private equity firm founded in 2022. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01.01.2023 |
Ehemalige bekannte Positionen von Kaia Roman
| Unternehmen | Position | Ende |
|---|---|---|
Psycheceutical, Inc.
 Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Private Equity Investor | 01.07.2023 |
Ausbildung von Kaia Roman
| New College of Florida | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Health Technology |
KetaMD, Inc.
KetaMD, Inc. Medical/Nursing ServicesHealth Services Part of Braxia Scientific Corp., KetaMD, Inc. operates as a telemedicine company. The company is based in Miami, FL. The company was founded in 2019 by Zappy Zapolin, Warren Gumpel, Leann Taylor, Kaia Roman. Warren Gumpel has been the CEO since 2019. KetaMD was acquired by Braxia Scientific Corp. on August 03, 2022 for $5.93 million. | Health Services |
Seedfund Capital
Seedfund Capital Investment ManagersFinance SeedFund Capital (SeedFund Capital) is a venture capital and private equity firm founded in 2022. The firm is headquartered in Chicago, Illinois. | Finance |
